4/A//SEC Filing
BioAmber Inc. 4/A
Accession 0001209191-14-010950
CIK 0001534287operating
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:29 PM ET
Size
7.9 KB
Accession
0001209191-14-010950
Insider Transaction Report
Form 4/AAmended
BioAmber Inc.BIOA
Hartmann Michael A.
Executive Vice President
Transactions
- Purchase
Common Stock
2013-05-14+10,000→ 16,720 total - Purchase
Common Stock Warrants (right to buy)
2013-05-14+10,000→ 10,000 totalFrom: 2013-08-08Exp: 2017-05-09→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The reported securities are included within 10,000 Units purchased by the reporting person on May 14, 2013 for $10.00 per Unit in connection with the Issuer's initial public offering. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock
- [F2]This Form 4/A amends the Form 4 filed on May 16, 2013, which inadvertently reported Common Stock Warrants (right to buy) under Disposed Derivative Securities.
Documents
Issuer
BioAmber Inc.
CIK 0001534287
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001534287
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:29 PM ET
- Size
- 7.9 KB